Bringing Gene Therapies to Life: Navigating Scale Up, Partnerships, and Barriers

Cell and gene therapies are rapidly advancing and with that, the need to effectively generate large volumes of viable cell and gene therapy products to fuel the pipeline. In this fast-paced industry, researchers, manufacturers, life science companies, and academics are working together to solve the significant challenges. Join Corning and Expression Therapeutics in a discussion about their experiences transitioning from R&D to upstream manufacturing for gene therapies: navigating many variables and overcoming obstacles to innovate the process and make novel gene therapies a reality. This discussion will cover: - Key challenges and considerations for moving gene therapies into clinical trials - How to overcome challenges in manufacturing with creative thinking to push technologies forward - How industry partnerships are evolving and how you can leverage them to drive innovation Roundtable Guests: William Swaney, M.S., President, Expression Manufacturing LLC Gabriela Denning, Ph.D., Vice President of Research & Development, Expression Therapeutics Anindya Dasgupta, Ph.D., Director GMP Manufacturing, Expression Manufacturing LLC